These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33357358)

  • 1. Influences of renal anemia on the pathology of IgA nephropathy: a study based on propensity score matching.
    Li F; Wei RB; Wang Y; Su TY; Li QP; Li P; Chen XM
    Discov Med; 2020; 30(159):7-18. PubMed ID: 33357358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.
    Chai L; Cai K; Wang K; Luo Q
    J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Association of Low Hemoglobin Levels with IgA Nephropathy Progression: A Two-Center Cohort Study of 1,828 Cases.
    Zhu B; Liu WH; Yu DR; Lin Y; Li Q; Tong ML; Li YY; Yang RC; Du YY; Tang XL; Jiang F; Fei D; Wei XY; Zhang FF; Yin JZ; Wang WR; Li XF; Sun Y; Zhong YZ; Zhang MJ; Cheng XX; Zhu CF; Chen HY
    Am J Nephrol; 2020; 51(8):624-634. PubMed ID: 32694247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of high body mass index with development of interstitial fibrosis in patients with IgA nephropathy.
    Wu C; Wang AY; Li G; Wang L
    BMC Nephrol; 2018 Dec; 19(1):381. PubMed ID: 30594167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictive value of free thyroxine combined with tubular atrophy/interstitial fibrosis for poor prognosis in patients with IgA nephropathy.
    Yang B; Zhou W; Cui L; Tian L; Ni Y; Yang M; Yang Y
    Front Endocrinol (Lausanne); 2024; 15():1372824. PubMed ID: 38808109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study.
    Gong WY; Liu M; Luo D; Liu FN; Yin LH; Li YQ; Zhang J; Peng H
    BMC Nephrol; 2019 Apr; 20(1):150. PubMed ID: 31039758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble interleukin-2 receptor alfa predicts renal outcome in IgA nephropathy.
    Lundberg S; Lundahl J; Gunnarsson I; Sundelin B; Jacobson SH
    Nephrol Dial Transplant; 2012 May; 27(5):1916-23. PubMed ID: 21940483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperuricemia and hypertriglyceridemia indicate tubular atrophy/interstitial fibrosis in patients with IgA nephropathy and membranous nephropathy.
    Liu B; Zhao L; Yang Q; Zha D; Si X
    Int Urol Nephrol; 2021 Nov; 53(11):2321-2332. PubMed ID: 33895976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased Serum C3 Levels in Immunoglobulin A (IgA) Nephropathy with Chronic Kidney Disease: A Propensity Score Matching Study.
    Yang X; Wei RB; Wang Y; Su TY; Li QP; Yang T; Huang MJ; Li KY; Chen XM
    Med Sci Monit; 2017 Feb; 23():673-681. PubMed ID: 28166191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anemia in Diabetic Patients Reflects Severe Tubulointerstitial Injury and Aids in Clinically Predicting a Diagnosis of Diabetic Nephropathy.
    Ito K; Yokota S; Watanabe M; Inoue Y; Takahashi K; Himuro N; Yasuno T; Miyake K; Uesugi N; Masutani K; Nakashima H
    Intern Med; 2021 May; 60(9):1349-1357. PubMed ID: 33250462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is it possible to predict the evolution of IgAN? Validation of the IgA nephropathy progression calculator and its relationship with MEST-C score in our population.
    Martín-Penagos L; Benito A; Oviedo MV; López Del Moral Cuesta C; Martín López J; Gómez Román J; López-Mejías R; Fernandez-Fresnedo G; Ruíz San Millán JC; Rodrigo Calabia E
    Nefrologia (Engl Ed); 2019; 39(5):523-530. PubMed ID: 30902505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary uromodulin excretion predicts progression of chronic kidney disease resulting from IgA nephropathy.
    Zhou J; Chen Y; Liu Y; Shi S; Wang S; Li X; Zhang H; Wang H
    PLoS One; 2013; 8(8):e71023. PubMed ID: 23990922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and pathological factors of renal anaemia in patients with IgA nephropathy in Chinese adults: a cross-sectional study.
    Wang Y; Wei RB; Su TY; Huang MJ; Li P; Chen XM
    BMJ Open; 2019 Jan; 9(1):e023479. PubMed ID: 30647035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time series changes in pseudo-R2 values regarding maximum glomerular diameter and the Oxford MEST-C score in patients with IgA nephropathy: A long-term follow-up study.
    Kataoka H; Ohara M; Suzuki T; Inoue T; Akanuma T; Kawachi K; Manabe S; Ushio Y; Kawasoe K; Akihisa T; Sato M; Iwasa N; Sawara Y; Honda K; Mochizuki T; Tsuchiya K; Nitta K
    PLoS One; 2020; 15(5):e0232885. PubMed ID: 32379841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum miR-192 Is Related to Tubulointerstitial Lesion and Short-Term Disease Progression in IgA Nephropathy.
    Fan Q; Lu R; Zhu M; Yan Y; Guo X; Qian Y; Zhang L; Dai H; Ni Z; Gu L
    Nephron; 2019; 142(3):195-207. PubMed ID: 30808829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
    Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y
    BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cigarette smoking may accelerate the progression of IgA nephropathy.
    Wang S; Qin A; Pei G; Jiang Z; Dong L; Tan J; Tan L; Tang Y; Qin W
    BMC Nephrol; 2021 Jun; 22(1):239. PubMed ID: 34187402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower serum bilirubin is associated with poor renal outcome in IgA nephropathy patients.
    Jiang Z; Tan J; Wang S; Dong L; Han X; Tang Y; Qin W
    Int J Med Sci; 2021; 18(13):2964-2970. PubMed ID: 34220324
    [No Abstract]   [Full Text] [Related]  

  • 19. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.
    Riispere Ž; Laurinavičius A; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
    Medicina (Kaunas); 2016; 52(6):340-348. PubMed ID: 27932191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy.
    Mise K; Hoshino J; Ueno T; Hazue R; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
    Diabetes Metab Res Rev; 2015 Sep; 31(6):572-81. PubMed ID: 25533683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.